文献速递糖尿病

长期使用质子泵抑制剂与2型糖尿病风险:一项大型人群巢式病例对照研究结果

Prolonged Use of Proton Pump Inhibitors and Risk of Type 2 Diabetes: Results From a Large Population-Based Nested Case-Control Study.
PubMed 文献 · J Clin Endocrinol Metab · 2022-01-01

在意大利伦巴第地区2010至2015年间新接受质子泵抑制剂(PPI)治疗的777420例患者队列中嵌套病例对照研究,将截至2020年诊断糖尿病的50535人与按年龄、性别和临床状态随机匹配的等量对照比较。与使用PPI不足8周者相比,使用8周至6个月、6个月至2年及超过2年者糖尿病风险分别升高19%、43%和56%。结论认为规律且长期使用PPI与糖尿病风险升高相关,医生应避免不必要的长期处方。

要点

  • 与PPI使用不足8周者相比,使用8周至6个月者糖尿病风险升高19%(95%CI 15-24)。
  • 使用6个月至2年者风险升高43%(95%CI 38-49),超过2年者升高56%(95%CI 49-64)。
  • 年轻患者及临床复杂度更差者中观察到的比值比更高。

核心结论

  • 规律且长期使用PPI与糖尿病风险升高相关,医生应避免不必要地处方此类药物,尤其是长期使用。

研究设计与样本

  • 在意大利伦巴第地区2010至2015年间新接受PPI治疗的777420例患者队列中开展巢式病例对照研究。
  • 截至2020年诊断糖尿病的50535人与按年龄、性别和临床状态随机选取的等量对照匹配。
  • 采用条件logistic回归模型估计比值比和95%CI,并调整多个协变量。
  • 进行敏感性分析评估结果的稳健性。

主要发现

  • 与使用PPI不足8周者相比,使用8周至6个月者糖尿病比值比升高19%(95%CI 15-24)。
  • 使用6个月至2年者糖尿病比值比升高43%(95%CI 38-49),使用超过2年者升高56%(95%CI 49-64)。
  • 按年龄、性别和临床特征分层分析结果一致,年轻患者及临床复杂度更差者中比值比更高。
  • 敏感性分析显示该关联一致且稳健。

临床怎么用

  • 作者结论认为医生应避免不必要地处方PPI,尤其是长期使用。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: It is still debated whether prolonged use of proton pump inhibitors (PPIs) might affect metabolic health. OBJECTIVE: To investigate the relationship between prolonged use of PPIs and the risk of developing diabetes. METHODS: We performed a case-control study nested into a cohort of 777 420 patients newly treated with PPIs between 2010 and 2015 in Lombardy, Italy. A total of 50 535 people diagnosed with diabetes until 2020 were matched with an equal number of controls that were randomly selected from the cohort members according to age, sex, and clinical status. Exposure to treatment with PPIs was assessed in case-control pairs based on time of therapy. A conditional logistic regression model was fitted to estimate the odds ratios and 95% CIs for the exposure-outcome association, after adjusting for several covariates. Sensitivity analyses were performed to evaluate the robustness of our findings. RESULTS: Compared with patients who used PPIs for < 8 weeks, higher odds of diabetes of 19% (95% CI, 15-24), 43% (38-49), and 56% (49-64) were observed among those who used PPIs for between 8 weeks and 6 months, 6 months and 2 years, and > 2 years, respectively. The results were consistent when analyses were stratified according to age, sex, and clinical profile, with higher odds ratios being found in younger patients and those with worse clinical complexity. Sensitivity analyses revealed that the association was consistent and robust. CONCLUSIONS: Regular and prolonged use of PPIs is associated with a higher risk of diabetes. Physicians should therefore avoid unnecessary prescription of this class of drugs, particularly for long-term use.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Ciardullo S, Rea F, Savaré L, et al. Prolonged Use of Proton Pump Inhibitors and Risk of Type 2 Diabetes: Results From a Large Population-Based Nested Case-Control Study. J Clin Endocrinol Metab. 2022. PMID: 35428888. doi:10.1210/clinem/dgac231

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。